低侵襲緑内障手術装置市場：装置、適応症、手術、エンドユーザー別-世界予測2025-2030年

低侵襲緑内障手術装置市場は、2023年に5億135万米ドルと評価され、2024年には5億2,662万米ドルに達すると予測され、CAGR 5.35％で成長し、2030年には7億2,255万米ドルに達すると予測されています。

低侵襲緑内障手術（MIGS）装置は眼圧を下げるように設計されており、主に軽度から中等度の緑内障患者に使用されます。従来の手術法に比べて侵襲性が低いことから、眼科手術における極めて重要な開発品となっています。MIGS装置の範囲は、世界人口の高齢化、緑内障の有病率の増加、より安全な代替治療への需要による必要性を包含しています。これらのデバイスは、ステントやシャントなど様々な形態で適用可能であり、眼科医によって単独で、あるいは白内障手術と併用して定期的に使用されています。最終用途の範囲には診療所、病院、外来手術センターが含まれるが、熟練した専門家と高度な設備が利用できることから、現在は病院が優位を占めています。

MIGS市場の主な成長促進要因としては、加齢に伴う眼障害の発生率の上昇や緑内障に関する意識の高まりが挙げられます。また、外来手術への嗜好の高まりも市場拡大を後押ししています。発展途上地域でのアクセシビリティと普及を高めるために、先進的でありながら費用対効果の高い装置の開発にビジネスチャンスがあります。企業は、技術のアップグレードや新しい手術手技の探求に重点を置いた研究や提携に投資することが推奨されます。しかし、MIGS装置は高価であること、術後に合併症を引き起こす可能性があること、熟練した専門家の数が限られていることなどから、市場は限界に直面しています。

厳しい規制要件や特定地域での償還政策の欠如といった課題も、市場の成長を阻害する可能性があります。イノベーションを促進するために、企業は次世代の生体適合性材料の開発とデバイスの使い勝手の向上に注力すべきであり、これによって応用範囲がさらに広がる可能性があります。患者に特化した治療オプションや個別化ケアモデルの調査は、事業成長のための貴重なフロンティアとなります。MIGS市場は緩やかな競争を特徴としており、主要プレーヤーは競争上の優位性を維持するために研究開発に注力しています。

市場力学：急速に進化する低侵襲緑内障手術装置市場の主要市場インサイトを公開

低侵襲緑内障手術装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 低侵襲手術機器への嗜好の高まり
  • 世界の老人人口の増加
  • 低侵襲手術機器の採用を促進する緑内障早期発見に対する意識の高まり
• 市場抑制要因
  • 低侵襲緑内障手術装置のコスト高
• 市場機会
  • 革新的で効果的な緑内障手術装置の研究開発への投資の増加
  • 遠隔医療と遠隔患者モニタリングの進歩
• 市場の課題
  • 新しい緑内障手術機器導入のための規制上のハードルと長い承認プロセス

ポーターの5つの力：低侵襲緑内障手術装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：低侵襲緑内障手術装置市場における外部からの影響の把握

外部マクロ環境要因は、低侵襲緑内障手術装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析低侵襲緑内障手術装置市場における競合情勢の把握

低侵襲緑内障手術装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス低侵襲緑内障手術装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、低侵襲緑内障手術装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨低侵襲緑内障手術装置市場における成功への道筋を描く

低侵襲緑内障手術装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 低侵襲手術機器の好感度が増加
    • 世界的に高齢化が進む
    • 緑内障の早期発見に関する意識の高まりにより、低侵襲手術機器の導入が促進されている
  • 抑制要因
    • 低侵襲緑内障手術装置のコストが高い
  • 機会
    • 革新的で効果的な緑内障手術機器の研究開発への投資増加
    • 遠隔医療と遠隔患者モニタリングの進歩
  • 課題
    • 新しい緑内障手術機器の導入には規制上のハードルと長い承認プロセスが必要
• 市場セグメンテーション分析
  • デバイス：緑内障の初期から中等度の段階の患者に対するマイクロステントの好感度が高まっている
  • エンドユーザー：病院における低侵襲緑内障手術（MIGS）機器の需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 低侵襲緑内障手術装置市場：デバイス別

• マイクロステント
• 脈絡膜上デバイス
• 線維柱帯デバイス
• 粘膜吻合装置

第7章 低侵襲緑内障手術装置市場適応症別

• 閉塞隅角緑内障
• 開放隅角緑内障

第8章 低侵襲緑内障手術装置市場手術別

• アブエクステルノ
• アブインテルノ

第9章 低侵襲緑内障手術装置市場：エンドユーザー別

• 外来手術センター
• 病院
• 眼科クリニック

第10章 南北アメリカの低侵襲緑内障手術装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の低侵襲緑内障手術装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの低侵襲緑内障手術装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ニューワールドメディカル、拡張されたカフックデュアルブレードの510（k）認可を取得、緑内障治療の選択肢と市場範囲を拡大
  • サイトサイエンシズのOMNI手術システムは緑内障治療において有望な結果を示し、より広範な採用と市場の成長を期待しています。
  • iSTAR Medical SA、緑内障治療機器でCEマークを取得、米国市場への進出を目指す
• 戦略分析と提言

企業一覧

• Abbott Medical Optics, Inc.
• Alcon Inc.
• Allergan PLC
• Bausch & Lomb Inc.
• Carl-Zeiss AG
• Corza Ophthalmology
• Ellex Medical Lasers Ltd.
• Glaukos Corporation
• InnFocus Inc.
• IOPtima
• iSTAR Medical
• Ivantis, Inc.
• Lumenis Be Ltd.
• Neomedix Corporation
• New World Medical, Inc.
• Optonol Ltd.
• Santen Pharmaceutical Co., Ltd.
• Sight Sciences, Inc.
• Topcon Corporation

LIST OF FIGURES

• FIGURE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICRO-STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY VISCOCANALOSTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CLOSED-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPEN-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 38. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 60. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 64. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 133. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 149. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 153. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Minimally Invasive Glaucoma Surgery Devices Market was valued at USD 501.35 million in 2023, expected to reach USD 526.62 million in 2024, and is projected to grow at a CAGR of 5.35%, to USD 722.55 million by 2030.

Minimally Invasive Glaucoma Surgery (MIGS) devices are designed to reduce intraocular pressure and are primarily used in patients with mild-to-moderate glaucoma. Their less invasive nature compared to traditional surgical methods makes them a pivotal development in ophthalmic surgery. The scope of MIGS devices encompasses their necessity due to the aging global population, the increasing prevalence of glaucoma, and the demand for safer alternative treatments. These devices are applicable in various forms, including stents and shunts, which are regularly used by ophthalmologists in both standalone procedures and in conjunction with cataract surgery. End-use scope includes clinics, hospitals, and ambulatory surgical centers, with hospitals currently dominating due to the availability of skilled professionals and advanced facilities.

The key growth drivers of the MIGS market include the rising incidence of age-related eye disorders and increasing awareness regarding glaucoma. Additionally, the growing preference for outpatient surgical procedures boosts market expansion. Opportunities lie in developing advanced, yet more cost-effective devices to increase accessibility and adoption in developing regions. Companies are recommended to invest in research and partnerships focused on technology upgrades and exploring new surgical techniques. However, the market faces limitations due to the high cost of MIGS devices, potential complications post-surgery, and a limited number of skilled professionals.

Challenges like stringent regulatory requirements and lack of reimbursement policies in certain regions could impede market growth. To foster innovation, businesses should focus on the development of next-generation biocompatible materials and enhancing device user-friendliness, which could further broaden their application range. Research into patient-specific treatment options and personalized care models represents a valuable frontier for business growth. The MIGS market is characterized by moderate competition, with key players focused on R&D to maintain competitive advantages and the entry of new companies bringing innovative solutions expected to invigorate the sector further.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Glaucoma Surgery Devices Market

The Minimally Invasive Glaucoma Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the preference for minimally invasive surgery devices
  • Rising geriatric population globally
  • Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
• Market Restraints
  • High costs of minimally invasive glaucoma surgery devices
• Market Opportunities
  • Increasing investment in research and development for innovative and effective glaucoma surgery devices
  • Advancements in telemedicine and remote patient monitoring
• Market Challenges
  • Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Glaucoma Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Glaucoma Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Glaucoma Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Glaucoma Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Glaucoma Surgery Devices Market

A detailed market share analysis in the Minimally Invasive Glaucoma Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Glaucoma Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Glaucoma Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Glaucoma Surgery Devices Market

A strategic analysis of the Minimally Invasive Glaucoma Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Glaucoma Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Corza Ophthalmology, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis Be Ltd., Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Glaucoma Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device, market is studied across Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices, and Viscocanalostomy Devices.
• Based on Indication, market is studied across Closed-Angle Glaucoma and Open-Angle Glaucoma.
• Based on Surgery, market is studied across Ab Externo and Ab Interno.
• Based on End-User, market is studied across Ambulatory Surgical Center, Hospital, and Ophthalmology Clinic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the preference for minimally invasive surgery devices
    • 5.1.1.2. Rising geriatric population globally
    • 5.1.1.3. Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of minimally invasive glaucoma surgery devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment in research and development for innovative and effective glaucoma surgery devices
    • 5.1.3.2. Advancements in telemedicine and remote patient monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device : Increasing preference for micro-stents for patients in the early-to-moderate stages of glaucoma
  • 5.2.2. End-user : Growing demand for minimally invasive glaucoma surgery (MIGS) devices in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Minimally Invasive Glaucoma Surgery Devices Market, by Device

• 6.1. Introduction
• 6.2. Micro-Stents
• 6.3. Suprachoroidal Devices
• 6.4. Trabecular Meshwork Devices
• 6.5. Viscocanalostomy Devices

7. Minimally Invasive Glaucoma Surgery Devices Market, by Indication

• 7.1. Introduction
• 7.2. Closed-Angle Glaucoma
• 7.3. Open-Angle Glaucoma

8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery

• 8.1. Introduction
• 8.2. Ab Externo
• 8.3. Ab Interno

9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Center
• 9.3. Hospital
• 9.4. Ophthalmology Clinic

10. Americas Minimally Invasive Glaucoma Surgery Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. New World Medical Secures 510(k) Clearance for Expanded Kahook Dual Blade, Enhancing Glaucoma Treatment Options and Market Reach
  • 13.3.2. OMNI Surgical System by Sight Sciences Shows Promising Results in Glaucoma Treatment, Anticipating Wider Adoption and Market Growth
  • 13.3.3. iSTAR Medical SA Achieves CE Mark for Glaucoma Device, Eyes Expansion into U.S. Market
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Medical Optics, Inc.
• 2. Alcon Inc.
• 3. Allergan PLC
• 4. Bausch & Lomb Inc.
• 5. Carl-Zeiss AG
• 6. Corza Ophthalmology
• 7. Ellex Medical Lasers Ltd.
• 8. Glaukos Corporation
• 9. InnFocus Inc.
• 10. IOPtima
• 11. iSTAR Medical
• 12. Ivantis, Inc.
• 13. Lumenis Be Ltd.
• 14. Neomedix Corporation
• 15. New World Medical, Inc.
• 16. Optonol Ltd.
• 17. Santen Pharmaceutical Co., Ltd.
• 18. Sight Sciences, Inc.
• 19. Topcon Corporation